Sharescart Research Club logo

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹31357 Cr.
Stock P/E
46.5
P/B
25.4
Current Price
₹9660
Book Value
₹ 379.8
Face Value
10
52W High
₹14536.6
52W Low
₹ 8995
Dividend Yield
1.81%

P&G Hygiene Overview

1. Business Overview

Procter & Gamble Hygiene and Health Care Ltd. (PGHH) is an Indian subsidiary of the global consumer goods giant Procter & Gamble. The company is primarily engaged in the manufacturing, marketing, and sale of a range of hygiene and healthcare products in India. Its core business model revolves around developing strong brands, leveraging extensive distribution networks, and consistent marketing to reach consumers. PGHH generates revenue by selling products such as Vicks (cold and cough remedies), Whisper (feminine hygiene products), and Old Spice (men's grooming products) through various retail channels across urban and rural India.

2. Key Segments / Revenue Mix

PGHH's revenue is primarily derived from two main product categories:

Healthcare: This segment includes products like Vicks VapoRub, Vicks Cough Drops, and Vicks Inhaler, targeting cold, cough, and flu relief.

Feminine Care: This segment is dominated by the Whisper brand, offering a range of sanitary pads and related feminine hygiene products.

Grooming: This segment includes Old Spice, primarily men's deodorants and body sprays.

While specific revenue percentages fluctuate, Healthcare and Feminine Care generally represent the dominant portions of the company's sales.

3. Industry & Positioning

PGHH operates within the highly competitive Indian Household & Personal Products industry, which is part of the larger Fast-Moving Consumer Goods (FMCG) sector. The industry is characterized by the presence of both large multinational corporations (MNCs) and strong domestic players. PGHH holds a leading position in its specific product categories; for example, Vicks is a strong player in the over-the-counter cold and cough market, and Whisper holds a significant market share in the feminine hygiene segment. The company leverages its global parent's expertise and brand strength to maintain its competitive standing.

4. Competitive Advantage (Moat)

PGHH possesses several durable competitive advantages:

Strong Brand Equity: Brands like Vicks and Whisper are household names in India, enjoying high consumer recall, trust, and loyalty built over decades.

Extensive Distribution Network: The company benefits from P&G's robust and deep distribution reach across urban and rural India, ensuring product availability.

R&D and Innovation: Backed by P&G's global R&D capabilities, PGHH can introduce innovative products and improve existing ones, adapting to local consumer needs.

Scale and Marketing Prowess: As part of a global giant, PGHH benefits from economies of scale in sourcing and manufacturing, and possesses significant marketing and advertising budgets to sustain brand visibility.

5. Growth Drivers

Key factors that can drive PGHH's growth over the next 3-5 years include:

Increasing Health & Hygiene Awareness: Growing awareness, particularly post-pandemic, for hygiene and health products can drive demand for Vicks and Whisper.

Rising Disposable Incomes & Premiumization: Growth in middle-class disposable incomes in India can lead to higher adoption rates and demand for premium product offerings.

Untapped Rural Markets: Expansion into Tier 2, Tier 3 cities, and deeper rural penetration for categories like feminine hygiene presents significant growth potential.

Category Expansion & Innovation: Introducing new product variants, sizes, and potentially expanding into adjacent categories under existing strong brands.

Digital Adoption: Increasing e-commerce penetration and digital marketing efforts can enhance reach and sales efficiency.

6. Risks

Intense Competition: The Indian FMCG market is highly competitive, with strong players like Hindustan Unilever, ITC, and numerous regional brands, leading to pricing pressures and market share battles.

Raw Material Price Volatility: Fluctuations in global commodity prices for raw materials can impact manufacturing costs and gross margins.

Regulatory Changes: Changes in health product regulations, advertising standards, or taxation policies (e.g., GST) can affect business operations and profitability.

Consumer Preference Shifts: Rapid changes in consumer preferences, new entrants, or lack of timely innovation can erode brand loyalty and market share.

Supply Chain Disruptions: Geopolitical events, natural disasters, or infrastructure issues can disrupt the supply chain, impacting production and distribution.

7. Management & Ownership

PGHH is promoted by Procter & Gamble, a global leader in consumer goods. The company operates with a professional management team, adhering to the high standards and strategic direction set by its parent company. The ownership structure typically involves Procter & Gamble holding a significant majority stake, with the remaining shares being publicly traded on Indian stock exchanges. This structure provides PGHH access to global resources, expertise, and best practices, while also having an independent board and management to oversee its Indian operations.

8. Outlook

PGHH benefits from a strong portfolio of established brands (Vicks, Whisper) that enjoy high consumer trust and extensive distribution in India. The underlying growth drivers of increasing health awareness, rising disposable incomes, and untapped market potential, particularly in feminine hygiene, provide a favorable backdrop for sustained growth. However, the company operates in a fiercely competitive market, necessitating continuous innovation, aggressive marketing, and efficient cost management to maintain its market leadership. Risks such as raw material inflation, shifts in consumer preferences, and intense competition will require vigilant strategic execution to navigate successfully. The strong backing of its global parent company provides a significant advantage in terms of R&D, brand building, and operational expertise.

P&G Hygiene Share Price

Live · BSE / NSE · Inception: 1964
| |
Volume
Price

P&G Hygiene Quarterly Price

Show Value Show %

P&G Hygiene Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 1138 1133 1002 932 1135 1248 992 937 1150 1262
Other Income 16 16 14 7 9 10 19 8 10 12
Total Income 1154 1149 1016 939 1144 1257 1011 945 1160 1274
Total Expenditure 853 824 745 813 845 877 782 671 865 860
Operating Profit 301 325 271 126 299 381 229 274 295 414
Interest 2 3 22 -0 2 7 6 0 4 3
Depreciation 14 14 15 13 12 10 10 9 9 10
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 284 309 234 112 285 364 213 265 282 402
Provision for Tax 74 80 80 31 73 96 57 73 72 101
Profit After Tax 211 229 154 81 212 269 156 192 210 301
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 211 229 154 81 212 269 156 192 210 301
Adjusted Earnings Per Share 64.9 70.5 47.6 25 65.3 82.7 48.1 59.2 64.7 92.9

P&G Hygiene Profit & Loss

#(Fig in Cr.) Jun 2015 Jun 2016 Jun 2017 Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024 Mar 2025 TTM
Net Sales 2334 2275 2320 2455 2947 3002 3574 3901 3918 4206 3374 4341
Other Income 76 88 79 24 55 44 56 30 45 68 38 49
Total Income 2409 2363 2399 2479 3002 3046 3630 3931 3963 4273 3413 4390
Total Expenditure 1850 1670 1658 1840 2339 2398 2706 3077 3054 3251 2504 3178
Operating Profit 559 693 742 639 663 648 924 854 909 1023 908 1212
Interest 6 6 10 5 5 6 6 11 11 27 14 13
Depreciation 53 52 60 52 50 48 48 53 58 57 32 38
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 501 636 672 582 607 594 870 790 839 939 862 1162
Provision for Tax 155 213 239 207 188 161 218 214 161 264 226 303
Profit After Tax 346 423 433 375 419 433 652 576 678 675 637 859
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 346 423 433 375 419 433 652 576 678 675 637 859
Adjusted Earnings Per Share 106.6 130.2 133.3 115.4 129.1 133.4 200.8 177.4 208.9 208 196.1 264.9

P&G Hygiene Balance Sheet

#(Fig in Cr.) Jun 2015 Jun 2016 Jun 2017 Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024 Mar 2025
Shareholder's Funds 1229 1652 526 806 909 1158 714 738 946 775 737
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities -1 -5 25 26 29 46 45 33 41 28 34
Total Current Liabilities 716 511 582 571 642 595 835 860 1085 981 901
Total Liabilities 1944 2157 1134 1402 1580 1799 1595 1631 2072 1784 1672
Fixed Assets 309 317 286 250 234 207 184 164 170 139 131
Other Non-Current Assets 278 208 245 316 256 264 294 332 406 445 434
Total Current Assets 1357 1632 603 815 1069 1321 1117 1135 1496 1200 1091
Total Assets 1944 2157 1134 1402 1580 1799 1595 1631 2072 1784 1672

P&G Hygiene Cash Flow

#(Fig in Cr.) Jun 2015 Jun 2016 Jun 2017 Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024 Mar 2025
Opening Cash & Cash Equivalents 266 615 1067 102 392 526 884 648 625 964 574
Cash Flow from Operating Activities 426 352 445 415 413 474 863 573 826 470 593
Cash Flow from Investing Activities 28 221 149 -19 34 75 7 -27 -10 1 -34
Cash Flow from Financing Activities -105 -122 -1559 -106 -314 -190 -1106 -569 -477 -861 -666
Net Cash Inflow / Outflow 349 452 -964 290 134 358 -236 -23 339 -390 -107
Closing Cash & Cash Equivalent 615 1067 102 392 526 884 648 625 964 574 466

P&G Hygiene Ratios

# Jun 2015 Jun 2016 Jun 2017 Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024 Mar 2025
Earnings Per Share (Rs) 106.64 130.16 133.31 115.4 129.12 133.42 200.8 177.37 208.92 207.95 196.12
CEPS(Rs) 122.82 146.08 151.72 131.53 144.46 148.17 215.48 193.66 226.89 225.36 205.96
DPS(Rs) 30.25 36 389 40 88 105 315 160 185 255 175
Book NAV/Share(Rs) 378.52 507.78 159.65 244.05 274.67 349.7 210.9 214.95 276.56 221.21 212.1
Core EBITDA Margin(%) 20.49 25.79 27.4 25.06 20.61 20.11 24.28 17.73 18.5 18.91 20.75
EBIT Margin(%) 21.46 27.32 28.2 23.91 20.8 19.98 24.51 17.24 18.22 19.14 20.9
Pre Tax Margin(%) 21.22 27.05 27.77 23.69 20.61 19.78 24.34 17 17.97 18.6 20.56
PAT Margin (%) 14.67 17.99 17.89 15.26 14.22 14.43 18.24 12.39 14.52 13.37 15.18
Cash Profit Margin (%) 16.89 20.18 20.36 17.39 15.91 16.02 19.57 13.52 15.77 14.49 15.94
ROA(%) 20.1 20.6 26.3 29.54 28.1 25.63 38.41 35.7 36.63 35.02 36.84
ROE(%) 31.02 29.37 39.95 57.17 49.79 42.74 71.64 83.3 85.01 83.56 90.52
ROCE(%) 45.4 44.56 62.65 88.18 71.48 58.05 93.58 110.39 101.08 112.29 115.95
Receivable days 15.47 20.48 21.31 20.91 20.43 21.14 15.76 13.13 15.95 16.52 23.72
Inventory Days 18.37 19.15 23 22.37 20.25 24.83 23.2 18.97 17.73 16.1 19.45
Payable days 119.33 143.65 137.09 148.01 140.88 178.06 202.36 179.52 192.14 206.08 241.53
PER(x) 63.52 48.24 60.36 85.8 82.91 76.11 66.38 75.57 68.47 79.92 69.36
Price/Book(x) 17.89 12.37 50.4 40.57 38.98 29.04 63.2 62.36 51.72 75.14 64.14
Dividend Yield(%) 0.45 0.57 4.83 0.4 0.82 1.03 2.36 1.19 1.29 1.53 1.29
EV/Net Sales(x) 9.16 8.49 11.21 12.93 11.61 10.68 11.92 10.99 11.6 12.69 12.94
EV/Core EBITDA(x) 38.22 27.84 35.05 49.64 51.63 49.49 46.13 50.19 49.99 52.18 48.08
Net Sales Growth(%) 13.79 -2.5 1.98 5.81 20.02 1.87 19.06 9.14 0.44 7.35 -19.77
EBIT Growth(%) 8.77 26.7 6.3 -13.94 4.38 -2.1 46.01 -8.52 6.18 13.56 -9.29
PAT Growth(%) 14.61 22.06 2.42 -13.44 11.89 3.33 50.5 -11.67 17.78 -0.46 -5.69
EPS Growth(%) 14.61 22.06 2.42 -13.44 11.89 3.33 50.5 -11.67 17.78 -0.46 -5.69
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 1.9 3.19 1.04 1.43 1.66 2.22 1.34 1.32 1.38 1.22 1.21
Quick Ratio(x) 1.73 2.94 0.73 1.21 1.35 1.87 1.04 1.05 1.18 0.99 0.96
Interest Cover(x) 88.55 102.36 65.47 110.36 111.83 98.84 143.37 71.61 74.77 35.79 61.29
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

P&G Hygiene Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 70.64 %
FII 0.97 %
DII (MF + Insurance) 15.97 %
Public (retail) 29.36 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 70.6470.6470.6470.6470.6470.6470.6470.6470.6470.64
FII 1.481.571.561.481.431.331.381.111.070.97
DII 15.2915.1115.1615.2815.3715.5115.4916.0516.0415.97
Public 29.3629.3629.3629.3629.3629.3629.3629.3629.3629.36
Others 0000000000
Total 100100100100100100100100100100

P&G Hygiene Peer Comparison

Household & Personal Products Edit Columns

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -20% -5% +2% +4%
Operating Profit CAGR -11% +2% +7% +5%
PAT CAGR -6% +3% +8% +6%
Share Price CAGR -32% -11% -6% +4%
ROE Average +91% +86% +83% +60%
ROCE Average +116% +110% +107% +82%

News & Updates

See more…

P&G Hygiene Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 86%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 206.08 to 241.53days.
  • Stock is trading at 25.4 times its book value.
  • The company has delivered a poor profit growth of 8% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp